Discover the power of predictive modeling to forecast future outcomes using regression, neural networks, and more for improved business strategies and risk management.
Patients with stage 3 colorectal cancer who tested MRD-positive with Signatera after surgery saw a meaningful survival ...
In April 2025, the U.S. Food and Drug Administration (FDA) released its Roadmap to Reducing Animal Testing in Preclinical Safety Studies—a landmark initiative that lays out a plan to make animal ...
The FDA’s emerging framework represents more than a regulatory update; it is a paradigm shift toward human-relevant, ...
By fusing behavioral data, real-time analytics and generative AI, the industry is entering a new era: attention hacking at ...
Proteomics International has secured a US patent for its PromarkerEso, a breakthrough blood test enabling early detection of ...
Cofactor Genomics, a commercial-stage diagnostics company transforming precision oncology through RNA-based predictive tests, today announced strategic investments from Labcorp and Ascension Ventures.
Automakers use AI-driven predictive maintenance and computer vision control to achieve a 35-50% reduction in unscheduled ...
AUDIENCEX, the leading integrated performance marketing and technology company, announced a year of robust growth fueled by advancements in AI, predictive intelligence, and customer expansion.
Its tests aren’t perfect, but they’re better predictors of college performance than anything anyone else is using.
New findings suggest blood tests still being assessed are showing promising results for early cancer screenings, especially ...
A retrospective real-world analysis presented at the 2025 ASH Annual Meeting and Exposition showed that circulating tumor DNA (ctDNA) detected at the end of treatment (EOT) was a prognostic indicator ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results